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GUEST EDITORIAL
The feasibility of testing experimentally the dietary fat-breast cancer
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Breast cancer is the commonest cause of death from cancer
in women in most of the Western world, and the leading
cause of death from all causes among women aged less than
50 (Silverberg & Lubra, 1988). Mortality from the disease
has not changed appreciably over an extended period of time
(Bailar & Smith, 1986). There is, however, considerable
evidence that breast cancer risk can be modified, and that
diet, particularly dietary fat, may play a major role in
influencing risk for the disease. The evidence that breast
cancer might be prevented has been reviewed by Doll & Peto
(1981). Breast cancer is approximately seven times more com-
mon in Northern Europe and North America than in Asia.
Since 1950 the disease has increased in incidence in Japan
and several other formerly low risk countries and rates in
Japanese migrants to the United States have risen to approx-
imately the level of Caucasians born in the USA. Changing
disease rates within countries and changing rates in migrants
make it plain that international differences in the frequency
of breast cancer are not due to inherited differences between
populations but rather are due to some difference in the
environment, which may be differences in dietary practices.
I. Dietary Fat Intake and Breast Cancer Risk
Dietary fat intake influences breast cancer risk in animals
(for recent reviews see Welsch, 1986; Rogers & Lee, 1986;
Welsch et al., 1985). In animals, increasing intake of dietary
fat increases tumour incidence, increases the number of
tumours that develop per animal, and decreases the latent
interval before the appearance of tumours. When given with
a carcinogen, dietary fat acts as a tumour promoter and
appears to have an effect on tumorigenesis that is indepen-
dent of caloric intake. Human ecological studies comparing
breast cancer incidence or mortality with dietary fat con-
sumption within countries show a more than 5-fold variation
in breast cancer rates between countries which is strongly
correlated (r = 0.8-0.9) with international variation in
estimated dietary fat intake. Countries with the highest
estimated fat intake in general also have the highest breast
cancer rates, and countries with the lowest fat intake the
lowest rates. Prentice et al (1988) have examined interna-
tional breast cancer rates and estimates of fat consumption
using regression analysis. Dietary fat intake explained more
of the international variation in breast cancer (58%) than did
total calories (14%), or any other dietary constituent con-
sidered, and the effect of fat remained highly significant after
controlling for differences in intake of total calories between
countries. Dietary fat remained significantly associated with
breast cancer rates after controlling for Gross National Prod-
uct, height, weight, and age at menarche (Prentice et al.,
1988). These analyses therefore showed a remarkably consis-
tent effect of dietary fat intake in explaining international
differences in the frequency of breast cancer.
Observational cohort and case control studies, however,
have given much less consistent results (for recent, contradic-
tory, reviews see Willett, 1989; Goodwin & Boyd, 1987; Schat-
zkin et al., 1989; Cohen, 1987; Rose, 1986; Carroll et al., 1986;
Howe et al., 1990). The largest of these is the Nurses Health
Study (Willet et al., 1987) which showed no association
between dietary fat intake and breast cancer risk in more than
100,000 nurses in the USA followed for 6 years. However it is
now recognised that the intake of dietary fat in 'western'
countries is remarkably homogeneous (Prentice et al., 1989;
Goodwin & Boyd, 1987). Given the narrow range of dietary
fat intake observed in the Nurses Health Study, and the error
known to be associated with the method used to measure fat
consumption in that study, it is unlikely that the study would
have found an association between fat intake and breast
cancer risk, even if international variation in breast cancer
rates is entirely due to differences in fat intake. Prentice et al.
(1988) have calculated that the Nurses Health Study had only
24% power to detect the 15% gradient in breast cancer risk
across the observed gradient in fat intake that would be
expected from international ecological data. Other observa-
tional studies, most of them substantially smaller than the
Nurses Health Study, have similar limitations. Observational
epidemiological studies, which are the conventional approach
taken to examine potential aetiological associations, are
therefore severely constrained in their ability to answer ques-
tions about the relationship of dietary fat intake to breast
cancer risk in humans. A recently reported case control study
from Italy (Tonioli et al., 1989), a country where dietary fat
intake is less homogeneous than in North America, reported a
strong association with breast cancer risk. Two other recently
reported studies (Verrault et al., 1988; Holm et al., 1989) have
shown that subjects with greater intake of dietary fat tend to
have more advanced tumours at the time of breast cancer
diagnosis, suggesting that fat may promote the growth of
human mammary cancers as it does in animals.
Experimental evidence, derived from controlled clinical
trials in which the range of fat intake is increased beyond
that seen in most Western populations, is capable of over-
coming this limitation of observational epidemiology, and
would provide the strongest evidence available for the rela-
tionship of dietary fat intake to breast cancer risk. Further-
more, such trials are the only means likely to answer the
question of whether breast cancer risk in high risk subjects
can be modified by changing dietary fat intake.
Previous work has been concerned with several aspects of
the feasibility of an experimental approach to this problem,
including the identification of subjects at increased risk for
breast cancer, and the demonstration that such subjects will
enter a clinical trial of dietary fat reduction and comply with
a low-fat diet.
II. The identification of subjects at increased risk for breast
cancer
Several studies have now shown the mammographic
appearance of densities in the breast parenchyma referred to
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as 'dysplasia' to be associated with an increased risk of breast
cancer (for recent reviews see Saftlas & Szklo, 1987; Good-
win & Boyd, 1988). Brisson et al. (1988) have recently shown
that increased risk of breast cancer associated with mammog-
raphic densities persists for at least 9 years after its first
detection. Furthermore, recent evidence suggests that mam-
mographic dysplasia may be related to dietary fat intake and
to biochemical variables associated with fat consumption.
Brisson et al. (1989) have recently shown a relationship
between dietary fat intake and high risk mammographic
patterns. Among 65 controls from the Canadian Breast
Cancer Screening Study, increasing intake of saturated fat,
assessed by a food frequency questionnaire of known
validity, was associated with a highly significant increase in
the extent of the mammographic densities that are associated
with breast cancer risk.
In recently completed work, we found that mammographic
dysplasia and a family history of breast cancer were both
independently associated with significantly higher levels of
high density lipoprotein cholesterol (HDL-C) after taking
into account the possible confounding effects of percent body
fat, parity and consumption of alcohol and dietary fat. Trig-
lyceride levels were also independently associated with a
family history of breast cancer (Boyd et al., 1989a). Further,
malonaldehyde, a mutagenic product of lipid peroxidation,
was measured in 24-hour urine samples from both groups
and excretion in women with mammographic dysplasia was
found to be approximately double that of women without
these radiological changes (P<0.02). This result suggests
that mammographic dysplasia may be associated with lipid
peroxidation and raises the possibility that mutagenic prod-
ucts generated by this process may influence breast cancer
risk (Boyd & McGuire, 1990). While further work is
obviously required to establish the relevance of these
biochemical findings to breast cancer risk, these results, add
to the evidence that factors related to fat metabolism may be
involved in the etiology of this disease.
III. Feasibility of intervention with a low-fat-high-carbohydrate
diet in women with mammographic dysplasia
The feasibility of a clinical trial involving a low-fat high-
carbohydrate diet in women with mammographic dysplasia
and the associated early outcomes have been published (Boyd
et al. 1988). It has been possible to recruit and retain subjects
with mammographic dysplasia in a randomised trial of
dietary intervention; subjects in the intervention group
showed close adherence to the dietary goals of the study as
assessed by food records, chemical analysis of duplicate
meals and serum cholesterol measurements, and the subjects
selected have been found to be at increased risk of breast
cancer. Only selected aspects of this work will be described
here. Further details are given in Boyd et al. (1988) and
Lee-Han et al. (1988). To date 595 subjects with extensive
mammographic dysplasia have entered the study. After entry,
subjects are allocated at random to receive either dietary
advice about balanced nutrition using Government
guidelines, but are not counselled to change their intake of
dietary fat, or are taught to reduce dietary fat intake to a
target of 15% of calories. Dietary compliance over 12
months has been described (Lee-Han et al., 1988; Boyd et al.,
1989b). Nutrient analysis of food records at baseline, shows
that the nutrient intake of control and intervention groups
resembled each other and the Canadian female population.
The nutrient intake of the control group remained stable
over 12 months of observation. Four months after ran-
domisation the mean total caloric intake fell from 1781 Kcal
to less than 1600 Kcal, and the mean percentage of calories
derived from fat, calorie adjusted, fell from 36% to 23%.
From 4 to 12 months after randomisation approximately
60% of the intervention group had an intake of dietary fat
that fell within 5% of the target of 15% of calories, and
approximately 80% had an intake within 10% of this target.
Protein intake was unchanged as a percent of total calories
but absolute intake fell 11%. Carbohydrate intake rose from
43% to 56% of calories but did not entirely replace the
reduced intake of calories from fat. Intake of both saturated
and polyunsaturated fat fell and the ratio of these sources of
fat did not change over 12 months. Intake of dietary
cholesterol also fell in the intervention group. Subjects have
now been followed for 24 months with similar results.
Dietary fat intake at 18 and 24 months after entry was
similar to that seen in subjects followed for 12 months, with
60% of subjects in the intervention group consuming less
than 20% of calories from fat and 80% consuming less than
25% of calories from fat. The mean fat intake of the
intervention group was similar to that reported for Japanese
women, and the variance less than for the Japanese (Kagawa,
1978). Further, no evidence of a change in dietary fat intake
in the control group has been observed over 24 months.
As described elsewhere (Boyd et al., 1989b), changes in
dietary fat consumption indicated in the food records were
supported by a quantitative relationship between nutrient
intake, and changes in serum cholesterol, as well as by
chemical analysis of all food consumed during one 24-h
period collected from 57 volunteer subjects. More extensive
data from 200 subjects is given in Boyd et al. (1990). In these
subjects serum cholesterol in women in the intervention
group fell in average of 8% at 4 months, 6% at 8 months
and 4% at 12 months. Predicted changes in serum cholesterol
were calculated by the formulae of Keys (1965) and Hegsted
(1965). Observed changes were significantly greater than the
changes predicted for subjects with initial serum cholesterol
values in the upper tertile of the population in whom serum
cholesterol fell 14% at 4 months, 12% at 8 months and 10%
at 12 months. Observed changes were not significantly
different from those predicted for subjects with baseline
values in the middle tertile, but were significantly less than
predicted for those with initial values in the lower tertile in
whom values rose 3% at 12 months. Regression analysis
indicates that the prediction of change in serum cholesterol
for a given change in diet is substantially better when the
model includes initial serum cholesterol value and change in
total fat intake (R2 = 0.41) than by the Keys or Hegsted
formulae (R2 = 0.04), which do not include initial serum
cholesterol value.
Thirteen invasive cancers have been found to date in this
population, 4.5 times the number expected (95% confidence
interval 2.4-7.7) based upon age-specific person-years of
follow up for the Ontario population. Excluding tumours
diagnosed within one year of entry, 9 cancers have occurred
(3.9 times the number expected; 95% confidence interval
1.34-6.87).
Thus, these results confirm that the subjects selected are at
increased risk for breast cancer and show that dietary
intervention involving a substantial reduction in fat intake is
feasible in this group of women. We next consider the sample
size that would be required to test the hypothesis that a
reduction in dietary fat intake will reduce risk of breast
cancer. The sample size, and the associated cost, are major
determinants of the feasibility of a clinical trial designed to
determine if breast cancer risk can be reduced.
IV. Sample size for a cancer prevention trial
The sample size for a trial is based upon the expectation that
cancer incidence will be reduced by 35% in the intervention
group. As is discussed below, the planned duration of this
trial is 10 years which will comprise 2 years of patient entry
and 8 years of follow up. The sample size will be sufficient to
provide an 80% probability of detecting an effect of this size.
1. Estimation ofcancer incidence in the controlgroup
We have estimated the cancer incidence of the control group
from data reported from the Breast Cancer Detection and
Demonstration Projects (BCDDP) (Brisson et al., 1988). This
report describes the breast cancer incidence over 9 years of880 N.F. BOYD et al.
observation in women with 'dense or glandular' breast paren-
chyma at entry (an appearance of the breast parenchyma that
corresponds approximately to the appearance of extensive
dysplasia that will be used to select subjects for the present
trial). This report shows that there is an increase in risk of
breast cancer in women with dense breast parenchyma at
entry, relative to women without dense breasts, that persists
for at least 9 years. The incidence of breast cancer according
to age at entry is shown below. Age-specific cancer risks were
applied to a population with the age distribution observed in
the 600 subjects enrolled in our trials to date to derive an
expected breast cancer incidence in the absence of the
intervention.
Age at entry CI' Annual Rate Proportion3
35-492 16.04 2.01 0.77
50-54 25.55 3.19 0.143
55-59 26.45 3.31 0.067
60-65 54.78 6.85 0.022
1. CI = cumulative incidence of breast cancer per 1000 over years
2 to 9. The data are taken from Table I of Brisson et al. (1988)
supplemented by information kindly supplied by Dr Brisson. These
rates have been used to calculate an average annual incidence (3rd
column) from which 10 year incidence has been estimated.
2. The distribution of subjects aged 35-49 in 5 year age groups
within the range 35-49 years is similar in the BCDDP and in our
present population. In both populations approximately equal pro-
portions of subjects are within each of these 5 year groups. In our
population 0.28, 0.26 and 0.23 of all subjects are respectively in the 5
year age groups 35-39, 40-44, 45-49. In the BCDDP 0.14, 0.17,
and 0.18 of all subjects were in these 5 year age groups. We have
therefore treated the age group 35-49 as a single category for the
purposes of risk calculations.
3. This column shows the proportion of subjects according to age
group in our present trial.
2. Estimation ofthe effect ofthe intervention
The risk reduction has been assumed to be linear and to
decline from 1.0 at the start to a final relative risk of 0.30 at
the end of 10 years. This estimate of the effect of the
intervention is derived from estimates of the effect of dietary
fat on breast cancer risk from international epidemiological
data, and from the 3-fold or greater changes in risk that have
been observed in migrants (Prentice et al., 1988). Because of
the age of the population, competing causes of death should
be negligible and have been ignored in the calculations.
3. Sample size required
Using an adaptation of the procedure described by Self et al.
(1988), taking into account the age distribution of the sub-
jects already enrolled, and assuming a linear decline in risk,
we calculate that 8400 subjects recruited over 2 years and
followed for 8 years will give an 80% probability ofdetecting
a relative risk of 0.3 at the end of 10 years. Because we
expect a drop out rate of approximately 4% in the first year
after entry and 1% per year thereafter, we need to recruit a
total of 9500 subjects to ensure that 8400 will remain in the
study at the end of 10 years. We expect 105 cancers in the
control group and 68 in the intervention group for a reduc-
tion in breast cancer incidence of 35%. Drop outs will also
be followed for the development of cancer but are not
included in these calculations.
The risk of breast cancer in the control group, however,
may be higher than estimated. Quantitative methods of clas-
sifying breast dysplasia, and standardised readers will be
used, rather than the qualitative methods of classification
used in the BCDDP. Quantitative methods of classifying
breast densities have in general identified groups of subjects
with higher risks of breast cancer than have qualitative
methods (Boyd et al., 1982; Brisson et al., Wolfe et al., 1987),
and while 5% of subjects in BCDDP with dense breasts had
first degree relatives with breast cancer (Saftlas et al., 1986),
20% of subjects recruited to date have at least 1 first degree
relative with breast cancer. Further, the observed cancer risk
in subjects enrolled to date is approximately double that
estimated from BCDDP data, even after the exclusion of
cancers diagnosed within 12 months of entry.
V. Conclusions
Animal and human ecological data suggest that dietary fat
may play a major role in the aetiology of breast cancer.
Human epidemiological evidence is, however, inconsistent
and because of the homogeneity of dietary fat intake in most
populations, does not exclude a strong association between
fat consumption and disease risk. Evidence now exists
indicating that the experimental study of the influence of
dietary fat reduction on breast cancer incidence is feasible in
a randomised controlled trial. Feasibility has been shown for
the recruitment and retention of subjects, for dietary comp-
liance and for the observed cancer risk of the subjects
selected. Further, the sample size required for such a trial is
attainable in Canada, and presumably elsewhere, by a mul-
ticentre trial. Such a trial would provide the strongest
evidence available concerning the relationship of dietary fat
intake to breast cancer risk, and is the only means to deter-
mine whether high risk subjects can reduce their risk by a
modification in diet.
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